Physician profile
Daniel R Grow
NPI 1619063310
$14,057.48
in general payments reported to CMS, 2019-2025
6 companies · $752 in 2025
The $752 reported for 2025 was more than what 91% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $1,357 · 2021: $325 · 2022: $9,755 · 2023: $654 · 2024: $469 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,716 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,715.59 |
| Education | $160.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $12,323.24 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $833.58 | 2019-2025 | Stripper |
| Merck Sharp & Dohme LLC | $341.18 | 2019-2021 | |
| Organon LLC | $288.51 | 2021-2025 | Ganirelix Acetate, Pregnyl |
| Emd Serono, INC. | $143.96 | 2019-2023 | |
| Ferring International Pharmascience Center US | $127.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Grow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.